ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63

BACKGROUND: Rare prostate carcinomas aberrantly express p63 and have an immunophenotype intermediate between basal and luminal cells. Here, we performed gene expression profiling on p63-expressing prostatic carcinomas and compared them to usual-type adenocarcinoma. We identify ETS2 as highly express...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostate
Autori principali: Torres, Alba, Alshalalfa, Mohammed, Davicioni, Elai, Gupta, Anuj, Yegnasubramanian, Srinivasan, Wheelan, Sarah J., Epstein, Jonathan I., De Marzo, Angelo M., Lotan, Tamara L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6818503/
https://ncbi.nlm.nih.gov/pubmed/29761525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23646
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi